SCHEMBL27798166

SCHEMBL27798166

CN1Cc2c(Br)cccc2N(Cc2cccc(F)c2)C1C=O

nearest known ligand 0.39

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
GRM2 Q14416 1/20 0.39
MEN1 O00255 3/20 0.38
KMT2A Q03164 3/20 0.38
ALDH1A1 P00352 3/20 0.36
SMN1; SMN2 Q16637 2/20 0.35
TP53 P04637 1/20 0.35
CYBB P04839 1/20 0.35
NOX5 Q96PH1 1/20 0.35
CHRM2 P08172 1/20 0.35
CHRM4 P08173 1/20 0.35
CHRM5 P08912 1/20 0.35
DRD2 P14416 2/20 0.35
DRD4 P21917 2/20 0.35
TDP1 Q9NUW8 2/20 0.34
UBE2N P61088 1/20 0.34
NPC1 O15118 1/20 0.34
RAB9A P51151 1/20 0.34
LMNA P02545 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4614643 0.74 KMT2A (0.46) GRM2MEN1KMT2AALDH1A1SMN1; SMN2
SCHEMBL28758597 0.67 DRD2 (0.38) MEN1KMT2AALDH1A1SMN1; SMN2DRD2
SCHEMBL27749333 0.64 GRM2 (0.41) GRM2MEN1KMT2AALDH1A1SMN1; SMN2
SCHEMBL28744195 0.63 MEN1 (0.40) MEN1KMT2AALDH1A1SMN1; SMN2CHRM2
SCHEMBL4616558 0.61 LMNA (0.43) GRM2MEN1KMT2ASMN1; SMN2TP53
SCHEMBL27850461 0.61 BRD4 (0.36) ALDH1A1SMN1; SMN2DRD2DRD4LMNA
SCHEMBL9572542 0.61 ALDH1A1 (0.60) MEN1KMT2AALDH1A1SMN1; SMN2CHRM2
SCHEMBL12062891 0.61 KMT2A (0.49) MEN1KMT2AALDH1A1SMN1; SMN2CHRM2
SCHEMBL3860379 0.61 CA2 (0.56) GRM2MEN1KMT2AALDH1A1CHRM5
SCHEMBL12719515 0.61 MAOB (0.40) KMT2AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1909909-B 1-benzyl-5-piperazin-1-yl-3, 4 dihydro-1H-quinazolin-2-one derivatives and each of 1H-benzo (1, 2, 6) thiadiazin-2, 2-dioxide and 1, 4-dihydro-benzo (D) (1, 3) × oxazin-2-one derivatives as 5-hydroxytryptamine receptor (5-HT) modulators for the treatment of central nervous system diseases HOFFMANN LA ROCHE 2010-12-15 CN disclosed